Search results
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It
Zacks via Yahoo Finance· 2 years agoNovavax (NVAX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is...
Novavax (NVAX) Q4 Earnings & Sales Miss Estimates, Stock Tanks
Zacks via Yahoo Finance· 4 months agoNovavax, Inc. NVAX reported a fourth-quarter 2023 loss of $1.44 cents per share, much wider than the...
Why Novavax Stock Hit a Fresh 52-Week Low Today
Motley Fool· 2 years agoShares of the recombinant-protein vaccine specialist Novavax (NASDAQ: NVAX) were down by a noteworthy 9.2% on heavy volume as of 9:55 a.m. ET on...
1 Reason to Buy Novavax Stock Hand Over Fist and 1 Reason to Sell
Motley Fool via Yahoo Finance· 5 months agoNovavax (NASDAQ: NVAX) shares have offered investors a roller coaster ride over the past few years....
Novavax (NVAX) Q1 Earnings Miss, Stock Soars on Sanofi Deal
Zacks via Yahoo Finance· 1 month agoNovavax (NVAX) partners with Sanofi to market its COVID-19 vaccine and also develop novel...
Novavax (NVAX) Q1 Earnings Lag, Stock Up 28% on Upbeat '23 View
Zacks via Yahoo Finance· 1 year agoNovavax (NVAX) reports dismal Q1 earnings results, as earnings and revenues miss estimates. However,...
Is It Too Late to Buy Novavax Stock?
Motley Fool via Yahoo Finance· 1 week agoNovavax (NASDAQ: NVAX) stock is suddenly a buy again this year, with its stock price more than tripling since the start of 2024. Some positive...
Why Novavax (NVAX) Stock Was Down 13% on Thursday
Zacks via Yahoo Finance· 2 years agoShares of Novavax, Inc. NVAX dropped 13.3% on Sep 22 after analysts at JP Morgan recently downgraded the stock’s recommendation from Neutral to...
Novavax Plummets On Downgrade: Is It The Covid Engine That Couldn't?
Investor's Business Daily· 1 year agoNovavax has a solid platform but continues to face a $700 million litigation headwind, an analyst...
Why Novavax and Johnson & Johnson Stocks Slipped Today
Motley Fool· 2 years agoWhat happened As a company, if the need for your latest and highest-profile product is declining...